Your session is about to expire
← Back to Search
Behavioural Intervention
5-Cog for Cognitive Impairment (5-Cog Trial)
N/A
Waitlist Available
Led By Joe Verghese, MBBS
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days after the participant is randomized
Awards & highlights
5-Cog Trial Summary
This trial will test whether the 5-Cog screen can help primary care doctors better identify patients with dementia.
Eligible Conditions
- Cognitive Impairment
- Mild Cognitive Impairment
- Dementia
- Neurocognitive Disorder
5-Cog Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days after the participant is randomized
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days after the participant is randomized
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
New Occurrence in Dementia Care-A Composite Endpoint Including New Cognitive Diagnoses, Laboratory Investigations Related to Cognitive Impairment, New Dementia Prescriptions, and Cognitive Related Referrals.
Secondary outcome measures
New Occurrence of in Health Care Utilization
Other outcome measures
Change in Health Care Utilization
Cost-effectiveness
5-Cog Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 5-CogExperimental Treatment1 Intervention
The 5-Cog coupled with a decision tree is a simple, 5-minute procedure that will identify older persons with cognitive impairment in primary care settings, and flag them for further evaluation. The 5-Cog includes the Picture Memory Impairment Screen (PMIS), Motoric Cognitive Risk syndrome (MCR), and the Symbol Match test. The 5-Cog will be given after randomization and before the patients sees the physician. The 5-Cog will sort patients with 'cognitive impairment' from those with 'no cognitive impairment'. After completing the 5-Cog, the non-physician tester will send a message through the Electronic medical record (EMR) system to provide the physician with the 5-Cog results and guide the them through the follow-up based on the results.
Group II: Health Literacy & Grip AssessmentActive Control1 Intervention
The 5 minute assessment includes the Short Assessment of Health Literacy (SAHL) and a grip assessment measured using a handgrip dynamometer. After completing the SAHL and grip assessment, the non-physician tester will send a message through the EMR to provide the physician with the results from the assessments and guide the them through the follow-up based on the results.
Find a Location
Who is running the clinical trial?
Albert Einstein College of MedicineLead Sponsor
286 Previous Clinical Trials
11,855,780 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,339 Previous Clinical Trials
648,105 Total Patients Enrolled
Joe Verghese, MBBSPrincipal Investigator - Albert Einstein College of Medicine
Albert Einstein College of Medicine
3 Previous Clinical Trials
125 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: 5-Cog
- Group 2: Health Literacy & Grip Assessment
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for new participants to join this trial?
"Currently, this medical experiment is not recruiting participants. The trial was initially listed on May 28th 2019 and last updated on September 30th 2022. Although it is inactive for now, there are other 932 trials in progress at the moment that are accepting volunteers."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger